VIRIOS THERAPEUTICS INC (VIRI) Stock Analyst Earnings Estimates
NASDAQ:VIRI - Nasdaq - US92829J1043 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 96.91% | N/A 40.00% | N/A 30.60% | |||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.96M | -2.18M -11.22% | -10.01M -359.17% | -15.64M -56.24% | -12.32M 21.23% | -5.447M 55.79% | N/A -1.04% | N/A -22.94% | N/A -60.61% | N/A 77.92% | N/A 284.12% | N/A 28.64% | N/A 45.14% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -1.31 37.35% | -0.28 78.63% | N/A 19.86% | N/A 25.00% | N/A -30.30% | N/A -234.88% | N/A 93.06% | N/A 260.00% | N/A 262.50% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 -19.00% | -0.05 27.14% | -0.05 -2.00% | -0.05 97.51% | -0.06 14.29% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.558M -36.85% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -2.05 -3,316.67% | -0.06 | -1.99 | -3,554.19% |
| Q2 2024 Q2Q % growth | -0.05 37.50% | -0.06 | 0.01 | 22.60% |
| Q1 2024 Q2Q % growth | -0.07 12.50% | -0.04 | -0.03 | -71.57% |
| Q4 2023 Q2Q % growth | -0.06 45.45% | -0.09 | 0.03 | 34.64% |
| Q3 2023 Q2Q % growth | -0.06 78.57% | -0.10 | 0.04 | 38.08% |
| Q2 2023 Q2Q % growth | -0.08 81.82% | -0.07 | -0.01 | -12.04% |
| Q1 2023 Q2Q % growth | -0.08 83.33% | -0.20 | 0.12 | 60.78% |
| Q4 2022 Q2Q % growth | -0.11 79.63% | -0.16 | 0.05 | 30.42% |
| Q3 2022 Q2Q % growth | -0.28 42.86% | -0.50 | 0.22 | 43.98% |
| Q2 2022 Q2Q % growth | -0.44 13.73% | -0.52 | 0.08 | 14.58% |
| Q1 2022 Q2Q % growth | -0.48 -29.73% | -0.55 | 0.07 | 12.04% |
| Q4 2021 Q2Q % growth | -0.54 56.80% | -0.69 | 0.15 | 21.57% |
| Q3 2021 Q2Q % growth | -0.49 | -0.71 | 0.22 | 30.88% |
| Q2 2021 Q2Q % growth | -0.51 | -0.57 | 0.06 | 10.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 8.33% | 0% | 18.52% |
| Revenue | N/A | N/A | N/A | N/A |